Oxbow Advisors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
ACM
WHG
Oxbow Advisors's BSX.PRA Position: Q3 2022 in Review
Oxbow Advisors sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q3 2022, closing a stake of 50,193 shares — an estimated $5.09M sold.
Oxbow Advisors first reported a position in BSX.PRA in Q4 2021 and held it in 3 quarters. The position peaked at $12M in Q4 2021. 54 funds tracked by Wall St. Rank hold BSX.PRA as of Q3 2022.
- Oxbow Advisors reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q3 2022 after selling out during the quarter.
- Oxbow Advisors sold 50,193 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q3 2022, an estimated $5.09M.
- Oxbow Advisors first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2021 and held it in 3 quarters.
- Oxbow Advisors's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $12M in Q4 2021.
- 54 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q3 2022.
Based on Oxbow Advisors's 13F filing for Q3 2022, filed 3 Nov 2022.